@Naueen
 Florida, USA
Joined September 2009
  • Tweets129
  • Following84
  • Followers119
Our paper on patterns of marijuana use in patients with Inflammatory Bowel Disease featured in Healio. Patients with IBD report ‘meaningful benefits’ in symptom relief with marijuana use healio.com/news/gastroentero…

Patients with IBD report ‘meaningful benefits’ in symptom relief with marijuana use

Patients with inflammatory bowel disease who used marijuana reported symptom relief, improved daily functioning and reduced opioid analgesic use, survey results showed.

healio.com
7
71
New research from the University of Florida examines cardiovascular risk associated with advanced therapies in #IBD. This systematic review and meta-analysis of 43 studies found no clear increase or decrease in major cardiovascular event risk with advanced therapies.
1
2
29
New research from the University of Florida finds that age, rather than social vulnerability, is associated with disparities in IBD prescription patterns. The nationwide Epic Cosmos study included more than 60,000 patients with IBD. sciencedirect.com/science/ar…
2
4
77
Hot off the press! Our latest study examines patterns of marijuana use, symptom response, and perceptions among individuals with IBD, with many reporting perceived improvements in symptom control and quality of life. #IBDresearch doi.org/10.1159/000553354

Marijuana Use for Symptom Control in Inflammatory Bowel Disease: Patients’ Perceptions and Patterns...

Abstract. Introduction: Many patients with inflammatory bowel disease (IBD) use marijuana for disease-related symptoms. Data regarding reasons for usage, impact, and perceptions on its effects is...

karger.com
1
2
74
Highlights from the IBUS Advanced Module 3 at the annual congress DDW 2026 in Chicago! 👏🏻 Many thanks to our outstanding faculty and participants for an inspiring and interactive program. Special appreciation to iUSCAN for co-organizing another memorable workshop 🤝🏻
1
3
12
414
Aniruddh Setya, MD will be leading our next UF IBD webinar! See flyer for more info. When: May 21st 6-7pm EST Where: Zoom Register here: ufl.zoom.us/webinar/register…
2
1
344
Another exciting @DDWmeeting 12 posters from the UF IBD group, 2 posters of distinction. Proud of our trainees. @UF_IBD #DDW2026
11
749
Using U.S. claims data, Chloe Jian found that GLP-1 RA use was associated with improved IBD-related outcomes compared with DPP-4 inhibitors among patients with type 2 diabetes and IBD, suggesting potential anti-inflammatory and disease-modifying effects of GLP-1 RAs #DDW2026
2
1
4
409
At #DDW2026, Chloe Jian examined biologic treatment patterns and adherence measurement in patients with IBD across pharmacy dispensing and HCPCS-coded medical claims, showing that biologic adherence estimates are highly sensitive to exposure definitions and claims capture routes.
2
4
376
At #DDW2026, Anshul Mahajan presented research on healthcare utilization in IBD patients with comorbid intellectual disability. Patients with ID-IBD had significantly higher clinic visits, ED visits, hospital days, and colonoscopies despite similar biologic use and surgical rates
2
4
88
At #DDW2026, Tomas Potlach reported a post-hoc analysis of the UNITI clinical trials for ustekinumab, highlighting differences in clinical response and remission during induction therapy between young adults aged 18-25 and older adults aged 26+.
1
6
176
At #DDW2026, Anshul Mahajan presented research on the prevalence of early-onset cataracts in young patients with IBD under age 50. Cataracts were rare overall, but cumulative corticosteroid exposure was identified as a key modifiable risk factor associated with increased risk.
2
6
452
At #DDW2026, Shay Bidani shared results from a national survey of college students with IBD. Over half reported academic disruptions, with key risk factors including prior surgery, off-campus housing, and minority status, highlighting opportunities for earlier, targeted support.
1
2
79
Go Gators! #DDW2026
5
9
2,341
Naueen Chaudhry retweeted
Venkata Sunkesula
@vsck123
May 5
Building lifelong mentorship and meaningful collaborations through American Gastroenterological Association (AGA) Best of Forward program. @BCryer @jalpa_devi @Naueen
2
1
15
398
Naueen Chaudhry retweeted
Yeshika Thapa@yessthapa767
May 3
Presenting my work at DDW 2026-grateful for the opportunity to share our research. ✨✨✨ @DDWMeeting @ibdtweets @BabuPMohan2 @Naueen #DDW2026 #GIResearch #Gastroenterology
3
15
724
Naueen Chaudhry retweeted
Jalpa Devi
@jalpa_devi
May 3
Replying to @jalpa_devi @AmerGastroAssn @DDWMeeting @ShivaniMattay @DarylRamai @SultanShazi @Jarshah4 @AGA_GIHN @UNMC_IBD @UNMCCOM @UNMC_GIHEP @kehutchins77 @PeakNatapatMD
@saia_gi 🤝 @AmerGastroAssn clinical research roundtable! 💫meeting w/ @P_DeepakIBDMD & running into our new chair @unmc @UNMCCOM #DrHemantRoy #AGAForwardProgram @BCryer @SandraQuezadaMD @MondayNightIBD @DCharabaty #DDW2026 @DDWMeeting
1
4
9
1,298
At #DDW2026, Nofel Iftikhar presented research on advanced therapies in IBD and their impact on neurodegenerative outcomes. Patients on advanced therapies demonstrated lower odds of neurodegenerative disorders, suggesting potential benefits that extend beyond IBD management.
1
3
93
At #DDW2026, Dr. Chris Miquel-Chambers looked at factors related to ostomy reversal in IBD patients using a large population dataset and classified reversal rates by IBD subtype and behavior. Congratulations on being selected as a poster of distinction!
2
4
114
New from Qi Jian and the UF IBD team in JAMA Network Open: Among 16,387 older adults with IBD, immunomodulators and biologics were not associated with increased MACE risk compared to 5-ASA over up to 3 years of follow-up. #IBD #HealthOutcomes jamanetwork.com/journals/jam…

Therapies for Inflammatory Bowel Disease and Major Adverse Cardiovascular Events

This comparative effectiveness study examines the association of inflammatory bowel disease treatment with immunomodulators or biologics vs 5-aminosalicylic acid with risk of major adverse cardiac...

jamanetwork.com
2
3
277
Load more